Oushadha Chandrika Ayurvedics (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.46 M
as on 16-12-2024
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.87 Cr
as on 16-12-2024
- Revenue %
(FY 2016)
- Profit 6.29%
(FY 2016)
- Ebitda 3.36%
(FY 2016)
- Net Worth -3.24%
(FY 2016)
- Total Assets -49.52%
(FY 2016)
About Oushadha Chandrika Ayurvedics (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.46 M.
The company has closed loans amounting to ₹1.87 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kallupalathingal Kochumon and Vijaya Raghavan serve as directors at the Company.
- CIN/LLPIN
U24233KL1998PTC012211
- Company No.
012211
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oushadha Chandrika Ayurvedics (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kallupalathingal Kochumon  | Managing Director | 27-Feb-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijaya Raghavan | Director | 17-Apr-1998 | Current |
Financial Performance of Oushadha Chandrika Ayurvedics (India).
Oushadha Chandrika Ayurvedics (India) Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 6.29% increase in profit. The company's net worth dipped by a decrease of 3.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oushadha Chandrika Ayurvedics (India)?
In 2017, Oushadha Chandrika Ayurvedics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2018 | ₹0.70 M | Satisfied |
The Federal Bank Limited Creation Date: 14 Sep 2013 | ₹0.90 M | Satisfied |
The Federal Bank Limited Creation Date: 03 Jan 2011 | ₹9.55 M | Satisfied |
How Many Employees Work at Oushadha Chandrika Ayurvedics (India)?
Unlock and access historical data on people associated with Oushadha Chandrika Ayurvedics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oushadha Chandrika Ayurvedics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oushadha Chandrika Ayurvedics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
